Angelina Jolie declared that her double mastectomy scars “are a choice” she is “grateful” she was able to make. “I’ve always been someone more interested in the scars and the life that people carry,” ...

An international team of scientists headed by researchers at the University of Edinburgh, has created a complete map showing how hundreds of possible mutations in a key cancer gene, CTNNB1, influence ...

Biomarker testing is crucial for personalized oncology care, aiding in risk stratification and treatment decisions, but faces challenges in uptake and education. Multistakeholder partnerships and ...

Washington — President Trump directed the Pentagon on Wednesday to resume testing of nuclear weapons "on an equal basis" with other countries' tests, possibly ending a decades-long U.S. pause that ...

BUSAN, South Korea (AP) — President Donald Trump appeared to suggest the U.S. will resume testing nuclear weapons for the first time in three decades, saying it would be on an “equal basis” with ...

"Clinicians performing tumor biopsy need to ensure that there’s adequate tissue for both diagnosis and NGS testing. Having immediate pathology review of biopsy specimens in the operating room can ...

NOTCH1 mutations, found in 20% of CLL cases, are associated with poor outcomes in chemotherapy but not yet in treatment guidelines. A retrospective analysis showed improved PFS for NOTCH1-mutated CLL ...

The risk of older fathers passing on disease-causing mutations to their children is higher than we thought. Genome sequencing has revealed that among men in their early thirties, around 1 in 50 sperm ...

In 2023, Jill Martin took a test that changed her life. She underwent genetic testing for breast cancer and learned she had a BRCA2 mutation, which increases one’s risk of developing breast and other ...

The Maelstrom Mutation was added to Grow a Garden on August 23, 2025, as part of the Beanstalk Update expansion. It's a mutation that requires combining two different ones to make it, so here's ...

In this on-demand webinar series, Dr. Igor Makhlin discusses personalized treatment options for ER-positive, HER2-negative metastatic breast cancer, including the role of ESR1 mutation testing and ...